Literature DB >> 7658266

Comparison of nasal prongs and nasopharyngeal catheter for the delivery of oxygen in children with hypoxemia because of a lower respiratory tract infection.

M W Weber1, A Palmer, A Oparaugo, E K Mulholland.   

Abstract

OBJECTIVE: To determine the best method of oxygen delivery for children in developing countries who have hypoxemia caused by acute lower respiratory tract infection.
METHODS: One hundred eighteen children between 7 days and 5 years of age with a lower respiratory tract infection and arterial hemoglobin oxygen saturation (Sao2) less than 90% were randomly selected to receive oxygen by nasopharyngeal (NP) catheter (n = 56) or nasal prongs (n = 62). A crossover study to determine the flow rate necessary to achieve an Sao2 of 95% was performed in 60 children.
RESULTS: One hundred twelve children could be oxygenated by the allocated method; in six oxygenation was poor with either method. The mean duration of therapy was 87.5 hours for the prongs and 94.9 hours for the NP catheter (not significant). The median oxygen consumption was 2142 L for prongs and 1692 L for the NP catheter (not significant). In the crossover study the prongs needed, on average, 26% higher oxygen flow rates than the NP catheter to obtain an Sao2 of 95% (p = 0.003). Complete nasal obstruction was observed in 24 of the children (44%) in the NP catheter group and in 8 (13%) in the prongs group (p < 0.001). Eighteen children died, 11 with NP catheter and 7 with prongs (not significant).
CONCLUSIONS: Because nasal prongs are less prone to complications, and oxygenation in children is equally effective, they are a more appropriate method than the NP catheter for oxygen delivery to children in developing countries with acute lower respiratory tract infections.

Entities:  

Mesh:

Year:  1995        PMID: 7658266     DOI: 10.1016/s0022-3476(95)70067-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

Review 1.  Acute bronchiolitis--recent advances in treatment.

Authors:  G J Canny
Journal:  Indian J Pediatr       Date:  1996 Jan-Feb       Impact factor: 1.967

Review 2.  Pneumonia research to reduce childhood mortality in the developing world.

Authors:  J Anthony G Scott; W Abdullah Brooks; J S Malik Peiris; Douglas Holtzman; E Kim Mulholland
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

Review 3.  Oxygen administration in infants.

Authors:  B Frey; F Shann
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-03       Impact factor: 5.747

4.  Hypoxemia predicts death from severe falciparum malaria among children under 5 years of age in Nigeria: the need for pulse oximetry in case management.

Authors:  Adebola Orimadegun; Babatunde Ogunbosi; Bose Orimadegun
Journal:  Afr Health Sci       Date:  2014-06       Impact factor: 0.927

Review 5.  An evaluation of oxygen systems for treatment of childhood pneumonia.

Authors:  Alastair G Catto; Lina Zgaga; Evropi Theodoratou; Tanvir Huda; Harish Nair; Shams El Arifeen; Igor Rudan; Trevor Duke; Harry Campbell
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

6.  Reservoir Cannulas for Pediatric Oxygen Therapy: A Proof-of-Concept Study.

Authors:  Grace Wu; Alec Wollen; Robert M DiBlasi; Stephen Himley; Eugene Saxon; Glenn Austin; Jaclyn Delarosa; Rasa Izadnegahdar; Amy Sarah Ginsburg; Darin Zehrung
Journal:  Int J Pediatr       Date:  2016-11-23

7.  A model for oxygen conservation associated with titration during pediatric oxygen therapy.

Authors:  Grace Wu; Alec Wollen; Stephen Himley; Glenn Austin; Jaclyn Delarosa; Rasa Izadnegahdar; Amy Sarah Ginsburg; Darin Zehrung
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

8.  Estimating oxygen needs for childhood pneumonia in developing country health systems: a new model for expecting the unexpected.

Authors:  Beverly D Bradley; Stephen R C Howie; Timothy C Y Chan; Yu-Ling Cheng
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.